Call Options Transactions Made in Q2 2023 in Stoke Therapeutics, Inc. (STOK)
This table provides information about the institutional ownership of Stoke Therapeutics, Inc. (STOK) during Q2 2023. The information is specifically focused on institutions that hold call options of Stoke Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
215KNew |
$1.71M - $2.97M
|
215K
$2.37M
|
|
|
Aug 14, 2023
Q2 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
43.6KNew |
$346K - $603K
|
43.6K
$480K
|
|
|
Aug 08, 2023
Q2 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
1.6KNew |
$12.7K - $22.1K
|
1.6K
$17.6K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-1.4K- 11.86% |
$11.1K - $19.3K
|
10.4K
$115K
|